NASDAQ · BBH

VanEck Biotech ETF (BBH)

$245.34−0.01%
Close Sep 28, 2026 · split-adjusted
Sep 28, 2026$245.34▲ 50.33% in range
Sep 29, 2025Low $163.20 · High $245.36Sep 28, 2026
What changed · written from our data
As of Sep 28, 2026

VanEck Biotech ETF closed at $245.34 on Sep 28, down 0.01% — matching its 52-week closing high. Volume of 10.3K shares was 0.83× its 20-day average (close to normal).

Split-adjusted performance: +1.4% over one month, +36.3% over six months, +52.4% over one year.

Short interest was 21.8K shares at the Sep 15 settlement, up 2.7% from the prior report (1.5 days to cover).

Market cap$492.3M2.0M shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yield0.39%$0.9565 last paid
52-week range161.02 – 245.360.0% from high
Volume10.3K0.83× 20-day avg
Volatility · 60d26.7%Annualised
Short % of float—1.5 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W +3.2%1M +1.4%3M +20.4%6M +36.3%YTD +29.6%1Y +52.4%3Y +57.2%5Y +14.8%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short21.8K+2.7% vs prior
Days to cover1.5Settled Sep 15
% of float—
Short vol. 10d44.1%of daily volume

Quick answers

What is BBH's market cap?
$492.27M, based on the Sep 28 close of $245.34.
Does VanEck Biotech ETF pay a dividend?
Yes. The latest regular dividend was $0.9565 per share (ex-date Dec 22), an annualised yield of 0.39%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology